Stefan Zajic

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Pain Management

Acute Lymphoblastic Leukemia

Diffuse Large B Cell Lymphoma

Prognostic Factors

Top Venues

Journal of pharmacokinetics and pharmacodynamics

This page only lists publications with an associated author ORCID identifier.

Publications

Dara Kusic, Jessica Marie Heil, Stefan Zajic, Andrew Brangan, Oluseun Dairo, Gretchen Smith, Diego Morales-Scheihing, Russell J Buono, Thomas N Ferraro, Rachel Haroz, Matthew Salzman, Kaitlan Baston, Elliot Bodofsky, Michael Sabia, Alissa Resch, Laura B Scheinfeldt
Patient Perceptions and Potential Utility of Pharmacogenetic Testing in Chronic Pain Management and Opioid Use Disorder in the Camden Opioid Research Initiative. Pharmaceutics 14 (9) (2022)
Taiga Nishihori, James E Hoffman, Anne Huff, Gurpreet S Kapoor, Ioanna Eleftheriadou, Stefan Zajic, Alisa Urbano, Sunil Suchindran, Michael J Chisamore, Jimson W D'Souza, Thomas Faitg, Aaron P Rapoport
Safety and efficacy of letetresgene autoleucel alone or with pembrolizumab for relapsed/refractory multiple myeloma. Blood advances (2022)
Stefan Zajic, S Aubrey Stoch, Jacqueline B McCrea, Rose Witter, Ghassan N Fayad, Monika Martinho, Julie A Stone
A phase 1 pooled PK/PD analysis of bone resorption biomarkers for odanacatib, a Cathepsin K inhibitor. Journal of pharmacokinetics and pharmacodynamics 47 (5) (2020)